Cannabis Use in People with Multiple Sclerosis and Spasticity: A Cross-Sectional Analysis
ConclusionsMany PwMS and spasticity use cannabis and report it helps their spasticity.
In conclusion, oculomotor impairment is a common component of disability in MS patients and should be considered when managing this type of patients. More research is still needed to know the real impact of this disease on binocular vision and accommodation. PMID: 32228341 [PubMed - as supplied by publisher]
Fatigue and poor sleep quality are among the most common patient-reported problems associated with multiple sclerosis (MS). Social support, on the other hand, is often found to be positively associated with quality of life in patients with neurological dis...
Publication date: Available online 1 April 2020Source: Journal of Clinical NeuroscienceAuthor(s): Emily Cheung, Jessica Hafner, Yi-Ching Lee, Sharon Coward, Amy Lofts, John Parratt, Karl Ng
Publication date: Available online 31 March 2020Source: Neurología (English Edition)Author(s): L.A. Rodríguez de Antonio, I. García Castañón, M.J. Aguilar-Amat Prior, I. Puertas, I. González Suárez, C. Oreja Guevara
Publication date: Available online 31 March 2020Source: The Brazilian Journal of Infectious DiseasesAuthor(s): Razieh Amini, Sajad karampoor, Hamid Zahednasab, Hossein Keyvani, Masoud Gheiasian, Farid Azizi Jalilian
AbstractIn the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient ’s empowerment in the decision-making process.AimsThe aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice.ResultsThe new resource, obtained by consensus am...
ZEPOSIA is a drug used for the treatment of adults with relapsing forms of multiple sclerosis (RMS) including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Publication date: Available online 1 April 2020Source: Redox BiologyAuthor(s): Zeina El Ali, Anthony Ollivier, Sylvie Manin, Michael Rivard, Roberto Motterlini, Roberta Foresti
AbstractPurposeCannabis has been used for thousands of years in many cultures for the treatment of several ailments including pain. The benefits of cannabis are mediated largely by cannabinoids, the most prominent of which are tetrahydrocannabinol (THC) and cannabidiol (CBD). As such, THC and/or CBD have been investigated in clinical studies for the treatment of many conditions including neuropathic pain and acute or chronic inflammation. While a plethora of studies have examined the biochemical effects of purified THC and/or CBD, only a few have focused on the effects of full-spectrum cannabis plant extract. Accordingly, ...